FDA and Russian Federation Revise Memorandum of Understanding on Drug Registration

Summary

The US Food and Drug Administration (FDA) has issued a revised annex to its 1994 Memorandum of Understanding with the Russian Federation, reaffirming cooperation on drug registration procedures and streamlining the process for U.S. pharmaceuticals in Russia.